For Big Drug Companies, a Headache Looms – New York Times
Pharmaceutical makers say that the agreements are a cost-effective way of settling patent litigation. In this month’s case in Philadelphia, In Re: K-Dur Antitrust Litigation, No. 10-2077, a three-judge panel unanimously ruled that lower courts ...
Subscribe to LegalLaw247.Com Newsletter
